Diabetes:肥胖相关的胰岛素抵抗与ScAT炎症相联系可为心脏病的预防提供线索

2020-11-09 MedSci原创 MedSci原创

肥胖相关的胰岛素抵抗(IR)可能会在多个器官中发展,代表了心脏代谢疾病的各种病因。

肥胖相关的胰岛素抵抗(IR)可能会在多个器官中发展,代表了心脏代谢疾病的各种病因。
研究人员通过对饮食、肥胖和基因(DiOGenes)(NCT00390637,ClinicalTrials.gov)队列(n = 368)的超重或肥胖参与者进行RNA测序,确定了肝脏或肌肉IR中的腹部皮下脂肪组织(ScAT)转录组谱。组织特异性IR表型来自于5点口服葡萄糖耐量试验。肝脏和肌肉IR由不同的腹部ScAT转录组图谱表征。
 
结果显示,与细胞外重塑相关的基因在以肝脏IR为主的个体中上调,而与炎症相关的基因在以肌肉IR为主的个体中上调。与此相一致,在两个独立的队列中,糖尿病和动脉粥样硬化马斯特里赫特队列(CODAM)(n = 325)和马斯特里赫特研究(n = 685),系统性低级炎症的增加与肌肉IR特别相关,但与肝脏IR无关。
研究认为,ScAT炎症基因表达的增加可能转化为系统性炎症概况的增加,将ScAT炎症与肌肉IR表型联系起来。这些不同的IR表型可能为更加个性化的预防心脏代谢疾病提供线索。
 
原始出处:
 
Birgitta W van der Kolk, Marianthi Kalafati, et al., Subcutaneous Adipose Tissue and Systemic Inflammation Are Associated With Peripheral but Not Hepatic Insulin Resistance in Humans. Diabetes. 2019 Dec;68(12):2247-2258. doi: 10.2337/db19-0560.  Epub 2019 Sep 6.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1750189, encodeId=4f7a1e5018995, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 30 01:07:33 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639646, encodeId=ce62163964699, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sat Aug 07 01:07:33 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761536, encodeId=60bd1e61536bf, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 01 07:07:33 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902516, encodeId=ab501902516ba, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Jan 26 17:07:33 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
    2021-06-30 baoya
  2. [GetPortalCommentsPageByObjectIdResponse(id=1750189, encodeId=4f7a1e5018995, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 30 01:07:33 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639646, encodeId=ce62163964699, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sat Aug 07 01:07:33 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761536, encodeId=60bd1e61536bf, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 01 07:07:33 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902516, encodeId=ab501902516ba, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Jan 26 17:07:33 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1750189, encodeId=4f7a1e5018995, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 30 01:07:33 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639646, encodeId=ce62163964699, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sat Aug 07 01:07:33 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761536, encodeId=60bd1e61536bf, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 01 07:07:33 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902516, encodeId=ab501902516ba, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Jan 26 17:07:33 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1750189, encodeId=4f7a1e5018995, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 30 01:07:33 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639646, encodeId=ce62163964699, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sat Aug 07 01:07:33 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761536, encodeId=60bd1e61536bf, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 01 07:07:33 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902516, encodeId=ab501902516ba, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Jan 26 17:07:33 CST 2021, time=2021-01-26, status=1, ipAttribution=)]

相关资讯

eLife:清华大学胡小玉课题组揭示miRNA在抑制肥胖中的作用机制

巨噬细胞是一类重要的免疫细胞,不仅参与调控免疫和炎症反应,也在维持机体代谢平衡方面发挥重要功能。miRNA是一类长度约为22 个核苷酸的非编码单链RNA分子,在基因的转录后调控中发挥重要功能。

GUT: 粪便病毒移植可减轻鼠模型中2型糖尿病和肥胖的症状

肥胖和2型糖尿病(T2D)的发展与肠道菌群(GM)的变化有关。肠道病毒群落以噬菌体(噬菌体)为主,噬菌体是以宿主特异性方式攻击细菌的病毒。

Diabetes Obes Metab:2型糖尿病患者肥胖与严重COVID-19结局之间的关系

在COVID-19住院的T2D患者中,超重和肥胖与早期预后不良相关。重要的是,在老年人中不再观察到肥胖对COVID-19预后的有害影响,这凸显了对该特定人群进行分类管理的必要性。

GUT: 肠道糖异生可预防肥胖相关的肝脂肪变性和非酒精性脂肪肝

肥胖引起的肝脂肪变性是全球范围内的主要健康问题,因为它可能引发非酒精性脂肪肝疾病(NAFLD)及其相关并发症,例如肝硬化或癌症。

Sci Adv:肥胖、糖尿病、心血管疾病等,是饮食与身体“不匹配”的结果?

该研究表明,从传统田园生活转向现代西方饮食的个体,健康状况普遍不佳;而且,终身居住在城市的居民将经历最大的心血管疾病风险。

年纪大了得阿尔茨海默病,可能是年轻时种下的果

很长一段时间,阿尔茨海默病都和年老捆绑在一起。人们通常觉得,随着年龄的增长,机体机能的退化,才使得患者的记忆力、理解力、判断力逐渐下降,生活自理能力丧失,发生一系列不良后果、乃至威胁到生命。